MacroGenics
MGNX
#9414
Rank
C$0.18 B
Marketcap
C$2.92
Share price
3.03%
Change (1 day)
46.54%
Change (1 year)

MacroGenics (MGNX) - Net assets

Net assets on the balance sheet as of June 2026 : C$61.41 Million

According to MacroGenics's latest financial reports the company has C$61.41 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

MacroGenics - Net assets on balance sheet (from 2012 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$C$76.13 M-54.29%
2024-12-31$C$0.16 B-17.73%
2023-12-31$C$0.20 B5.04%
2022-12-31$C$0.19 B-36.9%
2021-12-31$C$0.30 B-19.06%
2020-12-31$C$0.37 B25.25%
2019-12-31$C$0.30 B-8.96%
2018-12-31$C$0.33 B-12.06%
2017-12-31$C$0.37 B4.17%
2016-12-31$C$0.36 B-16.91%
2015-12-31$C$0.43 B208.82%
2014-12-31$C$0.14 B67.55%
2013-12-31$C$84 M-1125.54%
2012-12-31$-C$8.2 Million-53.94%
2011-12-31$-C$17.79 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
C$122.45 B 199,307.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$57.68 B 93,830.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$16.74 B 27,161.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$16.82 B 27,292.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$60.13 B 97,826.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$33.52 B 54,489.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
C$0.72 B 1,073.76%๐Ÿ‡บ๐Ÿ‡ธ USA